The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Nabumetone Tillomed 500 mg Film-coated Tablets

Tillomed Pharma GmbHPA22720/001/001

Main Information

Trade NameNabumetone Tillomed 500 mg Film-coated Tablets
Active SubstancesNabumetone
Dosage FormFilm-coated tablet
Licence HolderTillomed Pharma GmbH
Licence NumberPA22720/001/001

Group Information

ATC CodeM01AX Other antiinflammatory and antirheumatic agents, non-steroids
M01AX01 nabumetone


License statusAuthorised
Licence Issued14/07/2017
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back